Major Smith & Nephew investors call for break-up of medical device maker healthcare Three of Smith & Nephew's biggest shareholders are reportedly urging the FTSE 100 firm to break up if it cannot improve performance.
Growing demand for hip and knee replacements help Smith and Nephew to growth industrials Orthopaedic sales grew by 4.4 per cent over the quarter, thanks to "growth in hip and knee implants outside the US."
